Literature DB >> 20673138

Isolation and characterization of mesenchymal stem cells from human amniotic membrane.

Silvia Díaz-Prado1, Emma Muiños-López, Tamara Hermida-Gómez, Ma Esther Rendal-Vázquez, Isaac Fuentes-Boquete, Francisco J de Toro, Francisco J Blanco.   

Abstract

INTRODUCTION: The human amniotic membrane is a highly abundant and readily available tissue that may be useful for regenerative medicine and cell therapy. AIM: To compare two previously published protocols for the isolation of human amnion mesenchymal stromal cells (hAMSCs), including their phenotypic characterization and in vitro potential for differentiation toward osteogenic, adipogenic, and chondrogenic mesodermal lineages.
MATERIALS AND METHODS: Human placentas were obtained from selected caesarean-sectioned births. Two different protocols (Alviano et al. (1) and Soncini et al. (2) ) for the isolation of hAMSCs were performed. After monolayer expansion of adherent cells from both protocols, the cells were characterized by flow cytometry and for multipotentiality, as assessed by their capability to differentiate toward adipocyte-, osteoblast-, and chondrocyte-like cells.
RESULTS: Both protocols yielded hAMSCs that showed plastic adherence, fibroblast-like growth, and well-defined human MSC markers. The cell yield and mesodermal differentiation capability of hAMSCs were higher in cells isolated using the Soncini protocol.
CONCLUSIONS: Our data demonstrated the successful isolation of hAMSCs from full-term placentas using two published protocols. Differences between the two protocols in cell yield and in vitro differentiation potential are shown.

Entities:  

Mesh:

Year:  2010        PMID: 20673138     DOI: 10.1089/ten.TEC.2010.0136

Source DB:  PubMed          Journal:  Tissue Eng Part C Methods        ISSN: 1937-3384            Impact factor:   3.056


  20 in total

Review 1.  Perinatal stem cells: A promising cell resource for tissue engineering of craniofacial bone.

Authors:  Jia-Wen Si; Xu-Dong Wang; Steve Gf Shen
Journal:  World J Stem Cells       Date:  2015-01-26       Impact factor: 5.326

2.  A comparison of isolation and culture protocols for human amniotic mesenchymal stem cells.

Authors:  Aisha Naeem; Nikita Gupta; Usra Naeem; Muhammad Jawad Khan; Mohamed A Elrayess; Wanxing Cui; Chris Albanese
Journal:  Cell Cycle       Date:  2022-04-12       Impact factor: 5.173

3.  Isolation and characterization of canine amniotic membrane-derived multipotent stem cells.

Authors:  Sang-Bum Park; Min-Soo Seo; Hyung-Sik Kim; Kyung-Sun Kang
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

4.  Comparative Characterization of Cells from the Various Compartments of the Human Umbilical Cord Shows that the Wharton's Jelly Compartment Provides the Best Source of Clinically Utilizable Mesenchymal Stem Cells.

Authors:  Arjunan Subramanian; Chui-Yee Fong; Arijit Biswas; Ariff Bongso
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

5.  Phenotype and multipotency of rabbit (Oryctolagus cuniculus) amniotic stem cells.

Authors:  Jéssica Borghesi; Lara Carolina Mario; Ana Claudia Oliveira Carreira; Maria Angélica Miglino; Phelipe Oliveira Favaron
Journal:  Stem Cell Res Ther       Date:  2017-02-07       Impact factor: 6.832

6.  Human amniotic mesenchymal stem cells-conditioned medium protects mice from high-fat diet-induced obesity.

Authors:  Hui-Lan Tan; Xiao-Hui Guan; Min Hu; Jie Wu; Rong-Zhen Li; Ling-Fang Wang; Hou-Da Huang; Zhen-Ping Yu; Xiao-Yu Wang; Yun-Fei Xiao; Ke-Yu Deng; Hong-Bo Xin
Journal:  Stem Cell Res Ther       Date:  2021-06-26       Impact factor: 6.832

7.  Isolation and characterization of equine amniotic membrane-derived mesenchymal stem cells.

Authors:  Min-Soo Seo; Sang-Bum Park; Hyung-Sik Kim; Jun-gu Kang; Joon-Seok Chae; Kyung-Sun Kang
Journal:  J Vet Sci       Date:  2013-02-05       Impact factor: 1.672

8.  The Immunosuppressive Activity of Amniotic Membrane Mesenchymal Stem Cells on T Lymphocytes.

Authors:  Fatemeh Alikarami; Fatemeh Yari; Naser Amirizadeh; Mahin Nikougoftar; Mohammad Ali Jalili
Journal:  Avicenna J Med Biotechnol       Date:  2015 Jul-Sep

9.  Cat amniotic membrane multipotent cells are nontumorigenic and are safe for use in cell transplantation.

Authors:  Atanasio S Vidane; Aline F Souza; Rafael V Sampaio; Fabiana F Bressan; Naira C Pieri; Daniele S Martins; Flavio V Meirelles; Maria A Miglino; Carlos E Ambrósio
Journal:  Stem Cells Cloning       Date:  2014-08-27

10.  Intravenous C16 and angiopoietin-1 improve the efficacy of placenta-derived mesenchymal stem cell therapy for EAE.

Authors:  Ke-Wei Tian; Yuan-Yuan Zhang; Hong Jiang; Shu Han
Journal:  Sci Rep       Date:  2018-03-15       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.